文献速递流行病学与生物统计临床试验与 GCP

结肠镜腺瘤发现与长期结直肠癌发病风险的关联

Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence.
PubMed 文献 · JAMA · 2018-01-01

该研究基于PLCO癌症随机临床试验的多中心前瞻性队列,纳入15 935例首次乙状结肠镜筛查阳性后接受结肠镜的55-74岁参与者,随访至2013年。中位随访12.9年发现,晚期腺瘤者结直肠癌发病率显著高于无腺瘤者(RR 2.7,95%CI 1.9-3.7),而非晚期腺瘤者与无腺瘤者无显著差异(RR 1.2,95%CI 0.8-1.7)。

要点

  • 晚期腺瘤者长期结直肠癌发病风险显著增加(RR 2.7)。
  • 非晚期腺瘤者结直肠癌风险与无腺瘤者无显著差异。
  • 晚期腺瘤者结直肠癌死亡风险亦显著增加(RR 2.6)。

核心结论

  • 中位随访约13年,晚期腺瘤者结直肠癌发病和死亡风险显著高于无腺瘤者。
  • 非晚期腺瘤的发现可能并不与结直肠癌风险增加相关。

研究设计与样本

  • 多中心前瞻性队列研究,嵌套于PLCO癌症随机临床试验。
  • 纳入15 935例首次乙状结肠镜筛查阳性后接受结肠镜的55-74岁参与者,随访至2013年12月31日。

主要发现

  • 晚期腺瘤者结直肠癌发病率为20.0/10 000人年(95%CI 15.3-24.7;n=70)。
  • 非晚期腺瘤者发病率为9.1/10 000人年(95%CI 6.7-11.5;n=55)。
  • 无腺瘤者发病率为7.5/10 000人年(95%CI 5.8-9.7;n=71)。
  • 晚期腺瘤 vs 无腺瘤的结直肠癌发病RR为2.7(95%CI 1.9-3.7;P<.001)。
  • 非晚期腺瘤 vs 无腺瘤的发病RR为1.2(95%CI 0.8-1.7;P=.30),死亡RR为1.2(95%CI 0.5-2.7;P=.68)。

关键数值与推荐

  • 晚期腺瘤定义为≥1 cm、高级别异型增生或管状绒毛状/绒毛状组织学。
  • 非晚期腺瘤定义为<1 cm且无高级别组织学。
  • 晚期腺瘤 vs 无腺瘤的结直肠癌死亡RR为2.6(95%CI 1.2-5.7;P=.01)。

临床怎么用

  • 结肠镜发现晚期腺瘤者应加强结直肠癌 surveillance 和风险管理。
  • 非晚期腺瘤者的结直肠癌风险可能接近无腺瘤者,提示可考虑风险分层管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Individuals with adenomatous polyps are advised to undergo repeated colonoscopy surveillance to prevent subsequent colorectal cancer (CRC), but the relationship between adenomas at colonoscopy and long-term CRC incidence is unclear. OBJECTIVE: To compare long-term CRC incidence by colonoscopy adenoma findings. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, prospective cohort study of participants in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer randomized clinical trial of flexible sigmoidoscopy (FSG) beginning in 1993 with follow-up for CRC incidence to 2013 across the United States. Participants included 154 900 men and women aged 55 to 74 years enrolled in PLCO of whom 15 935 underwent colonoscopy following their first positive FSG screening result. The final day of follow-up was December 31, 2013. EXPOSURES: Enrolled participants had been randomized to FSG or usual care. Participants who underwent FSG and had abnormal findings were referred for follow-up. Subsequent colonoscopy findings were categorized as advanced adenoma (≥1 cm, high-grade dysplasia, or tubulovillous or villous histology), nonadvanced adenoma (<1 cm without advanced histology), or no adenoma. MAIN OUTCOMES AND MEASURES: The primary outcome was CRC incidence within 15 years of the baseline colonoscopy. The secondary outcome was CRC mortality. RESULTS: There were 15 935 participants who underwent colonoscopy (men, 59.7%; white, 90.7%; median age, 64 y [IQR, 61-68]). On initial colonoscopy, 2882 participants (18.1%) had an advanced adenoma, 5068 participants (31.8%) had a nonadvanced adenoma, and 7985 participants (50.1%) had no adenoma; median follow-up for CRC incidence was 12.9 years. CRC incidence rates per 10 000 person-years of observation were 20.0 (95% CI, 15.3-24.7; n = 70) for advanced adenoma, 9.1 (95% CI, 6.7-11.5; n = 55) for nonadvanced adenoma, and 7.5 (95% CI, 5.8-9.7; n = 71) for no adenoma. Participants with advanced adenoma were significantly more likely to develop CRC compared with participants with no adenoma (rate ratio [RR], 2.7 [95% CI, 1.9-3.7]; P < .001). There was no significant difference in CRC risk between participants with nonadvanced adenoma compared with no adenoma (RR, 1.2 [95% CI, 0.8-1.7]; P = .30). Compared with participants with no adenoma, those with advanced adenoma were at significantly increased risk of CRC death (RR, 2.6 [95% CI, 1.2-5.7], P = .01), but mortality risk in participants with nonadvanced adenoma was not significantly different (RR, 1.2 [95% CI, 0.5-2.7], P = .68). CONCLUSIONS AND RELEVANCE: Over a median of 13 years of follow-up, participants with an advanced adenoma at diagnostic colonoscopy prompted by a positive flexible sigmoidoscopy result were at significantly increased risk of developing colorectal cancer compared with those with no adenoma. Identification of nonadvanced adenoma may not be associated with increased colorectal cancer risk. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00002540.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Click B, Pinsky PF, Hickey T, et al. Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence. JAMA. 2018. PMID: 29800214. doi:10.1001/jama.2018.5809

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。